Home Your basket
• Cytokines profile in cyst...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• A non-linear model of lar...
   Price 10.50 €
• Blepharoplasty and upper ...
   Price 10.50 €
• Interventional phoniatry...
   Price 14.00 €
• Is ethmoidal adenocarcino...
   Price 10.50 €
• Long term results of KTP ...
   Price 5.50 €
• Osteoid osteomas in the f...
   Price 5.50 €
• Acceptability of topical ...
   Price 5.50 €
• Melanotic neuroectodermal...
   Price 8.50 €
• Cochlear implantation in ...
   Price 14.00 €
• Clinico-radiological cons...
   Price 10.50 €
• A specific plain X-ray in...
   Price 8.50 €
• Hearing preservation in p...
   Price 10.50 €
• Acquired non tumoral lary...
   Price 12.00 €
• Karapandzic flap for reco...
   Price 10.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Is HIV/AIDS an independen...
   Price 10.50 €
• Human skull development a...
   Price 10.50 €
• Importance of a molding n...
   Price 10.50 €
• Chondrocalcinosis of the ...
   Price 8.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Functional anatomy of the...
   Price 14.00 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• Acinic cell carcinoma in ...
   Price 8.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Laryngeal tracheal post-i...
   Price 8.50 €
• Scaling properties of the...
   Price 5.50 €
• Social consequence of a d...
   Price 10.50 €
• Intra oral approach versu...
   Price 12.00 €
• Voice after supracricoid ...
   Price 10.50 €
• The effects of treatments...
   Price 14.00 €
• Bilateral cleft lip and c...
   Price 14.00 €
• Periphery, central and ps...
   Price 10.50 €

Total Order 339.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2007 o

RHINOLOGY

Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis


Authors : Klossek J. M (Poitiers)

Ref. : Rev Laryngol Otol Rhinol. 2007;128,3:187-192.

Article published in french
Downloadable PDF document french



Summary : Sinusitis or acute rhinosinusitis, is defined as an acute viral or bacterial infection characterised by inflammation of the mucosa of the nose and paranasal sinuses. Although antibiotics are routinely prescribed for the treatment of acute sinusitis, most cases are caused by viral infections and will resolve without antibiotic therapy. Given concerns about global antibacterial resistance, evidence-based clinical practice guidelines recommend a conservative approach to antibiotic treatment, with mild or moderately severe acute sinusitis managed symptomatically. Intranasal corticosteroids act on the nasal mucosa to relieve inflammation and its associated symptoms, and may be a useful symptomatic treatment option. Two randomised, placebo-controlled trials have demonstrated that the corticosteroid mometasone furoate, administered as a nasal spray (MFNS), is effective as an adjunct to antibiotics in acute sinusitis. The design of these studies show a therapeutic approach known in Europe, but this attitude is still different from the current French guidelines. Furthermore, the efficacy and safety of MFNS monotherapy has been compared with antibiotic therapy in a randomised, double-blind, placebo-controlled trial in adults with acute uncomplicated sinusitis and probably viral. In this study, twice-daily (BID) MFNS 200 µg produced statistically greater improvements in overall symptoms and most individual symptoms compared with amoxicillin or placebo, even though Amoxicillin is not the one recommended by the French guidelines for this indication. These findings suggest that MFNS may play an important role in the management of acute sinusitis, either as monotherapy or as adjunctive treatment to antibiotics. These results lead also to think over its interest in the treatment of uncomplicated common forms of sinusitis, where antibiotics are still widely prescribed in daily practice.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE